Pharmacy Report Archives - Page 91 of 150 - Becker's Hospital Review

Drug prices up 6.6% in 2022 | San Francisco permits 3rd doses for J&J recipients | Mass. system ousts CEO | Merck antiviral effective against omicron | Watch for RX errors amid pharmacy staff shortages, physician warns

January 31, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Drugmakers raise prices 6.6% this year Full story 2. Incorrect prescriptions prompts physician warning: Check medication before leaving pharmacy Full story 3. San Francisco allows 3rd COVID-19 shot for J&J…

10 top drug safety concerns | Merck vs. Pfizer's antiviral: 11 notes | Pharmacist gets 5-year sentence in $180M fraud scheme | 'An invisible HHS secretary' | CDC reminds pharmacies of vaccine guidelines for immunocompromised

January 27, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 10 top medication safety concerns from 2021 Full story 2. CDC reminds pharmacies of vaccine guidelines for immunocompromised Full story 3. Pharmacist gets 5-year sentence in $180M healthcare fraud scheme Full…

Why 2 pharmacists left their roles | FDA blasts Eli Lilly for 'misleading' ads | Booster rates, by state | Insurers pay up to 74% of costs for ivermectin | 'Endemic' can be dangerous | Vaccine, treatment efficacy against omicron: 6 notes

January 26, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Why 2 pharmacists left their roles Full story 2. FDA blasts Eli Lilly for 'misleading' Instagram ads Full story 3. States ranked by booster rates: Jan. 26 Full story 4. Cedars-Sinai consistently hires…

27 drugs Mark Cuban's co. offers for at least $100 less | Some pharmacies deny 4th shots to immunocompromised | FDA limits use of 2 antibody drugs | Omicron deaths mirror delta wave | Immune protection lasts 4 mos. after Pfizer booster

January 25, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 27 medications with the biggest price cuts on Mark Cuban's online pharmacy Full story 2. FDA limits use of two COVID-19 antibody treatments due to omicron Full story 3. US pharmacies…

Remdesivir OK for outpatient use: FDA | CDC shifts focus from 'fully vaccinated' to 'up to date' | 12 drugmakers restricting 340B discounts | Patients can access Rx savings through their TVs | 6 COVID forecasts for the week

January 24, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. FDA authorizes remdesivir as outpatient COVID-19 treatment Full story 2. Patients can now access prescription savings through their TV Full story 3. Omicron will peak in most states by mid-February…

Kaiser to offer repeat vaccinations after dosage error | CMS faces pressure to expand Aduhelm coverage | Walgreens, VillageMD plan 8 clinics in Ariz. | 5.3M Medicare patients struggle to afford meds: study | 6 states where delta is lingering

January 20, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Kaiser to offer repeat COVID vaccinations to nearly 4,000 people who may have received low dose Full story 2. Patient groups, lobbyists pressure CMS to expand Aduhelm coverage Full story…

Mark Cuban's drug co. launches online pharmacy | Gilead uncovers $250M counterfeit drug scheme | 14 pharmacies with most COVID therapeutics | Pfizer antiviral works against omicron | CVS, Uber partner

January 19, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Mark Cuban's drug company launches online pharmacy Full story 2. Gilead says $250M in counterfeit HIV drugs ended up with patients Full story 3. 14 pharmacies with largest supply of COVID-19…

4th shot may be less effective against omicron | CVS, Walgreens temporarily close some pharmacies on weekends | Martin Shkreli banned from drug industry | 20 hospitals tied to most 'unnecessary' care | J&J, Merck & Novo invest in health data co.

January 18, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. 4th shot offers less protection against omicron, Israeli study suggests Full story 2. J&J, Merck and Novo invest in health data company Full story 3. 'Pharma bro' Martin Shkreli banned from…

Staff shortages temporarily close pharmacies nationwide | Novartis eyes emergency approval for COVID antiviral | Texas hospital loses Medicare contract | Layoffs hit Pfizer sales staff | Overdose deaths surge among older adults

January 13, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. Staff shortages spur temporary pharmacy closures nationwide Full story 2. 7 drugs likely to hit $1B in annual revenue in the next 5 years Full story 3. Pfizer cutting sales…

CMS plans to limit coverage of Aduhelm | J&J vaccine gets new warning | CVS, Walgreens limit paid sick leave | ONC shares e-prescribing guidelines | Omicron's spread, severity: 2 new findings

January 12, 2022 BHR Newsletter Virtual Events • Webinars • Whitepapers • OnDemand Learning • Podcasts 1. CMS unveils preliminary Aduhelm coverage decision Full story 2. CVS, Walgreens limit paid sick leave for employees Full story 3. FDA adds rare bleeding risk to J&J shot side effects Full story…